Arm Holdings Plc (NASDAQ: ARM) has issued a correction to its second-quarter fiscal year 2027 revenue guidance, clarifying that expected sales will range between $1.330 billion and $1.430 billion. This update replaces a previously disclosed and erroneous guidance range of $880 million to $1.88 billion. The company’s adjusted earnings per share (EPS) guidance for the quarter remains unchanged at $0.43 to $0.51, which aligns with the analyst consensus estimate of $0.43.

The correction addresses a significant discrepancy in the previously reported revenue outlook. Analysts had estimated second-quarter revenue at $1.339 billion. The revised guidance range of $1.330 billion to $1.430 billion now brackets this estimate more tightly, suggesting stable expectations for the period rather than the high variability implied by the earlier error. The EPS guidance continues to reflect management's confidence in profitability despite the clarification on top-line figures.

Corrected Guidance Figures

The following table outlines the corrected forward-looking metrics for Arm Holdings’ second quarter, compared to market expectations.

Context from Q1 Results

This guidance update follows Arm’s record-breaking first-quarter performance, where the company reported total revenue of $1.29 billion, beating analyst estimates of $1.26 billion. Earnings per share for Q1 were $0.45, surpassing the consensus of $0.40 by 12.5%. The strong start to the fiscal year was driven by a 22% year-over-year increase in royalty revenue to $715 million and a 23% rise in licensing revenue to $574 million.

Rene Haas, CEO of Arm Holdings, attributed the Q1 success to growing demand for the Arm compute platform across cloud infrastructure, edge devices, and AI applications. The disproportionate growth in data center royalties, which more than doubled year-over-year, signaled a structural shift toward high-value enterprise computing volumes.

What the Numbers Show

The correction of the revenue guidance removes an outlier scenario that suggested potential downside risk (the $880 million lower bound) or extreme upside (the $1.88 billion upper bound). By narrowing the range to $1.330 billion–$1.430 billion, Arm signals greater certainty in its near-term operational execution. The fact that the lower bound of the revised guidance ($1.330 billion) is only marginally below the analyst estimate ($1.339 billion) indicates that the company expects to meet or exceed market expectations, provided no unforeseen delays occur in licensing deals or royalty accruals. This stability is crucial for investors who had noted slight downward pressure on the stock following the initial Q1 results release.

Arm Holdings plc shares dropped 7.41% to $246.60 on Tuesday as investors pulled back from high-growth technology stocks amid renewed caution in the AI supply chain. The decline followed losses in key memory makers SK hynix Inc and Micron Technology Inc, which fell 8%-9%, sparking debate over whether memory producers are capturing too much of the AI economics and if hyperscalers will sustain capital spending. While S&P 500 futures rose 0.34%, Nasdaq futures slipped 0.76%, reflecting broad pressure on high-multiple names despite Arm’s longer-term growth trajectory.

The selloff was exacerbated by weakness in South Korean markets, driven by concerns about AI infrastructure demand and Chinese competition. This broader risk-off sentiment in the semiconductor sector has intensified scrutiny on crowded positions in AI-related equities. Arm’s stock movement underscores the volatility inherent in the current AI infrastructure cycle, where sentiment shifts rapidly based on spending signals from major cloud providers.

Technical Analysis

Arm remains under pressure in the short term, trading 16.3% below its 20-day simple moving average (SMA) of $293.32 and 24.1% below its 50-day SMA of $323.51. These metrics indicate that the intermediate trend has weakened significantly. However, the stock retains a constructive long-term outlook, sitting 30.1% above its 200-day SMA of $188.84 and just 0.4% above its 100-day SMA of $244.77. The proximity to the 100-day SMA suggests this level acts as a critical support zone.

Earnings & Analyst Outlook

Arm is scheduled to report financial results for the first quarter of fiscal year 2027 on July 29, 2026, after market close. Wall Street maintains a Buy consensus with an average price forecast of $306.74, ranging from a high of $500.00 to a low of $140.00 across 50 analysts. The implied valuation stands at a P/E ratio of 313.3x, highlighting the premium investors continue to place on the company’s growth prospects.

Recent analyst actions reflect mixed sentiment:

• Wells Fargo maintained an Overweight rating but lowered its price forecast to $350.00 on July 22.
• Susquehanna reiterated a Positive rating and raised its price forecast to $320.00 on July 21.
• UBS maintained a Buy rating while lowering its price forecast to $360.00 on July 20.

ETF Exposure

Arm carries significant weight in major semiconductor and technology ETFs, which can amplify trading activity through fund flows.

Because Arm holds such heavy weight in these funds, any significant inflows or outflows will likely force automatic buying or selling of the stock, adding to short-term volatility.